| Name | Title | Contact Details |
|---|
Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the bodys response to foreign material, the companys technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use.
Pontotoc Technology Center (PTC) has a diverse economy with a large health community including Mercy Hospital, Chickasaw Nation Health System and Rolling Hills Psychiatric Hospital. Pontotoc also has a large mining sector with Holcim, Unimin, and Fairmount Minerals, a large manufacturing sector with Flex-N-Gate and Solo Cup and a large service industry with Pre Paid Legal Services dba Legal Shield and Interactive Response Technologies. These diverse sectors are served in a rural setting.
C5 MedicalWerks is a Grand Junction, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
scanlan international inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack